New building in Singapore is home of region's largest clinical development
RESEARCH TRIANGLE PARK, N.C., Sept. 10 /CNW/ -- Quintiles Transnational
Corp. announced today that it will expand its Singapore operations to meet the
surging demand for its business in the Asia-Pacific region. The new regional
headquarters will be double the size of its existing presence in Singapore and
will be the home of the region's largest clinical development organization.
Quintiles' Asia-Pacific growth also has led to expansion of seven local
offices in the region and the addition of a new location in Indonesia.
"Quintiles is the largest and fastest growing clinical development group
in Asia," said Dennis Gillings, CBE, Chairman and Chief Executive Officer.
"Since entering the region in the 1990s, we have built a strong staff of 2,800
clinical development professionals, representing a total of 23 nationalities,
who have worked in more clinical trials and with more investigator sites than
any other single organization in Asia."
Anand Tharmaratnam, M.D., Head of Clinical Development, Quintiles Asia
Pacific, said the expanded facility renews the company's commitment to the
region and to its partnership with the Singapore Economic Development Board
"Our growth in Singapore has been bolstered by the expanding base of
companies and research institutes in Singapore's larger biomedical sciences
research community," Tharmaratnam said. "We are projecting continued strong
growth in the future, and this new facility gives us the room we will need.
The new location also will allow us to work more efficiently, share best
practices and deliver truly turnkey solutions to our customers."
"Quintiles was the first contract research organization to set up
operations here. Its continued growth since the mid 1990s is testament to
Singapore's attractiveness as a home base from which contract research
organizations as well as pharmaceutical companies manage and coordinate their
clinical trials activities in Asia. Quintiles' expansion of its regional
headquarters also reaffirms Singapore's position as Asia's leading location
for headquarters activities," said Dr Beh Swan Gin, Managing Director,
Singapore Economic Development Board.
Quintiles' Central Laboratory and its Clinical Development Services (CDS)
offices will move into approximately 80,000 square feet of space in the
Cintech IV building now under construction in Singapore's Science Park One.
The move is planned in the 3rd quarter of 2009.
Quintiles also has expanded offices recently in Manila, Taipei, Seoul,
Kuala Lumpur, Bangkok, Sydney and Hong Kong. The company also has opened an
office in Jakarta. In Singapore, Quintiles presently has about 225 employees,
occupying close to 40,000 square feet of space in three locations. The new
location has a capacity of about 400.
Quintiles entered the Asia Pacific region in 1993 with offices in Japan
and Australia before establishing its Singapore office in 1995. Since then,
the company has conducted more than 1,000 studies involving more than 6,500
sites and more than 160,000 patients in the region.
Quintiles Transnational Corp. is powering the next generation of
healthcare by providing a broad range of professional services in drug
development, financial partnering and commercialization for the
pharmaceutical, biotechnology and healthcare industries. With more than 21,000
employees and offices in more than 50 countries, it is focused on providing
customer-centric solutions that are the gold standard of the industry. For
more information, please visit the company's Web site at www.quintiles.com.
For further information:
For further information: Dick Jones, Media Relations, +1-919-998-2091,
email@example.com, or Greg Connors, Investor Relations,
+1-919-998-2000, firstname.lastname@example.org, both of Quintiles Transnational Corp.
Web Site: http://www.quintiles.com